Calcium signaling in cultured human and rat duodenal enterocytes

Catherine S. Chew1,2, Bengt Säfsten1, and Gunnar Flemström1

1 Department of Physiology, Uppsala University, SE-751 23 Uppsala, Sweden; and 2 Institute for Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 31902

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Vagal stimuli increase duodenal mucosal HCO-3 secretion and may provide anticipatory protection against acid injury, but duodenal enterocyte (duodenocyte) responses and cholinoceptor selectivity have not been defined. We therefore developed a stable primary culture model of duodenocytes from rats and humans. Brief digestion of scraped rat duodenal mucosa or human biopsies with collagenase/dispase yielded cells that attached to the extracellular matrix Matrigel within a few hours of plating. Columnar cells with villus enterocyte morphology that exhibited spontaneous active movement were evident between 1 and 3 days of culture. Rat duodenocytes loaded with fura 2 responded to carbachol with a transient increase in intracellular calcium concentration ([Ca2+]i), with an apparent EC50 of ~3 µM. In a first type of signaling pattern, [Ca2+]i returned to basal or near basal values within 3-5 min. In a second type, observed in cells with enlarged vacuoles characteristic of crypt cell morphology, the initial transient increase was followed by rhythmic oscillations. Human duodenocytes responded with a more sustained increase in [Ca2+]i, and oscillations were not observed. Rat as well as human duodenocytes also responded to CCK-octapeptide but not to vasoactive intestinal polypeptide. Equimolar concentrations (100 nM) of the subtype-independent muscarinic antagonist atropine and the M3 antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide prevented the response to 10 µM carbachol, whereas the M1 antagonist pirenzepine and the M2 antagonists methoctramine and AF-DX 116BS had no effect at similar concentrations. Responses in rat and human duodenocytes were similar. A new agonist-sensitive primary culture model for rat and human duodenocytes has thus been established and the presence of enterocyte CCK and muscarinic M3 receptors demonstrated.

cholecystokinin; calcium oscillations; muscarinic M3 receptors; primary culture of duodenal enterocytes

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

HCO-3 SECRETION by the duodenal mucosa alkalinizes the viscoelastic mucus gel adherent to the epithelial cell surface, providing an important first line of duodenal mucosal defense against hydrochloric acid in the intestinal lumen. In addition, centrally elicited vagal activation of the secretion presumably provides anticipatory protection against acid discharged from the stomach. Vagally mediated stimulation of duodenal alkaline secretion has been demonstrated in all species studied (8, 10). Several studies (15, 19, 22, 27, 29) of intact animals and isolated mucosa have also sought to characterize the mechanisms of both extrinsic vagal and enteric nervous control of secretion. In these studies, it has been shown that the nonselective muscarinic antagonist atropine inhibits the stimulation of mucosal HCO-3 secretion by the cholinomimetics carbachol and bethanechol in anesthetized rats (19, 27, 29) and guinea pigs (22) in vivo as well as in rabbit mucosa in vitro (15). There is, however, some controversy with respect to the type and subtypes of cholinoceptors involved in mediating this stimulation. One such study in the rat (27) provided evidence for involvement of nicotinic as well as muscarinic M1 receptors. Further evidence for the involvement of M1 receptors is the inhibition of basal secretion in human subjects (21) and of secretion stimulated by carbachol in the guinea pig (22) by the M1-selective antagonist pirenzepine. Another study in the rat (29), however, suggested the involvement of muscarinic M2 receptors. Interestingly, atropine also inhibits secretion stimulated by vasoactive intestinal polypeptide (VIP) in the guinea pig in vivo (22) and in rabbit mucosa in vitro (15). This suggests the possibility that there are interactions between muscarinic- and peptidergic-mediated stimulation of duodenal mucosal HCO-3 secretion.

Despite the physiological importance of duodenal HCO-3 secretion and its regulation, neither the duodenal enterocyte (duodenocyte) signaling mechanisms nor the specific receptors present on these cells have been characterized. Because muscarinic agonists have several possible sites of action in the intestine, including ion-transporting enterocytes, postsynaptic axons, and presynaptic terminals in the enteric nervous system, it is likely that one site of action will dominate in a particular experimental protocol. The use of isolated duodenocytes would thus seem a prerequisite for the demonstration of actions of muscarinic and other stimuli on duodenocyte receptors at the cellular level and for the evaluation of agonist-responsive intracellular signaling pathways.

The aim of the present investigation was thus to develop an agonist-responsive duodenocyte model and to begin to characterize the suitability of this model for defining cell-specific intracellular signaling pathways. We report the development of primary culture models of rat and human duodenocytes that retain agonist responsiveness for several days in culture. We further demonstrate, by measuring changes in intracellular calcium concentration ([Ca2+]i) within single cells, the presence of receptors for both cholinergic agonists and CCK (CCK-8) on the same duodenocytes. Pharmacological analyses at the single-cell level further indicate that the cholinergic receptors that linked to the Ca2+ signaling pathway are of the M3 subtype.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Isolation and primary culture of rat duodenocytes. Male rats (Lewis × Dark Agouti, 150-250 g; from Uppsala Biomedical Center breeding) were raised in a conditioning unit under standardized temperature and light conditions (21-22°C; 12:12-h light-dark cycle) and had access to pelleted food (Ewos, Södertälje, Sweden) and drinking water ad libitum. Animals were fasted in mesh-bottomed cages with free access to water for 20-24 h before cell isolation. All experiments were approved by the Ethics Committee for Experiments with Animals at Uppsala University.

Rats were decapitated to avoid the possible stimulatory effects of anesthetics on intestinal mucus release. A 3-cm segment of duodenum, starting just distal to the Brunner's glands was promptly excised via an abdominal midline incision and freed from mesentery. The segment was opened along the antemesenterial axis, rinsed with DMEM-Ham's nutrient mixture F-12 (DMEM-F12) (with 15 mM HEPES, no HCO-3), 0.01 mg/ml gentamicin, and 2.5% FCS. The mucosa was scraped off, minced, and then rinsed by settling two to three times in the same medium and suspended in 10 ml of pH 7.4 enzymatic dissociation medium (4) containing (in mM): 125.4 Na+, 5.4 K+, 1.0 Ca2+, 1.2 Mg2+, 121.8 Cl-, 1.2 SO2-4, 6.0 phosphate, 15.0 HEPES, 1.0 pyruvate, and 10 glucose plus 2 mg/ml sterile BSA (35% solution, Sigma cell culture grade), 300 U/ml collagenase type IA, 0.1 mg/ml dispase, and 10 mg/l phenol red. After a brief gassing with 100% O2, the tissue suspension was incubated in a horizontal shaking water bath for 20 min at 37°C at 96 rpm (CS20 shaker, Messgeräte-Werk, Lauda, Germany). A portion of the supernatant was then removed and tissue fragments further dissociated by trituration. The remaining nondissociated tissue was separated from dissociated cell groups by brief settling and trituration continued. Successive fractions of dissociated groups of cells (~10-20 cells/group) were immediately diluted with an 8-10× volume of sterile DMEM-F12 (with 15 mM HEPES, L-glutamine, no HCO-3), 0.01 mg/ml gentamicin, 2.5% FCS, and 0.5 mM dithiothreitol (DTT). Cell fractions were filtered through 200-µm nylon mesh (Saati, Como, Italy), washed three times by centrifugation (2-3 min at 500 g), and resuspended in the same medium. The final cell pellet was suspended (~0.1 ml cells in 3 ml medium) in culture medium composed of DMEM-F12 (with 15 mM HEPES, L-glutamine), 0.12% NaHCO3 (from a sterile 7.5% solution), 2.5-10% FCS, and 0.01 mg/ml gentamicin. Cells (30-50 µl) were plated by underlaying into 1.5 ml of culture medium in 35-mm Matrigel-coated culture dishes (50 µl of a 1:7 Matrigel/sterile H2O dilution), as previously described (5). Cells were allowed to settle onto Matrigel for ~15 min at room temperature then placed in a humidified 37°C water-jacketed CO2 incubator. HCO-3/CO2 was used because uptake of HCO-3 by NaHCO3 cotransport and export via both an anion channel and Cl-/HCO-3 exchange are important characteristics of the duodenocyte (8). Culture media were exchanged daily.

Isolation and primary culture of duodenocytes from human biopsies. Duodenal biopsies (2-3 from each individual, ~1-2 mm in diameter) were obtained from eight patients (7 female and 1 male, median age 51 yr, range 39-71 yr) undergoing upper endoscopy at the Department of Surgery, Uppsala University Hospital and found to have endoscopically normal duodenal and gastric mucosae. No antiulcer drugs (H+-K+-ATPase inhibitors or histamine H2-receptor antagonists), cholinergic antagonists, or sedatives had been administered for at least 5 days preceding endoscopy. The project was approved by the Ethics Committee of the Medical Faculty at Uppsala University, and all subjects provided written informed consent. Biopsies were immediately placed into 5 ml of sterile DMEM-F12 (plus 15 mM HEPES and L-glutamine, no HCO-3) containing 2.5% FCS and 0.01 mg/ml gentamicin, transported to the laboratory, rinsed, and minced in the same medium at room temperature within 20-40 min after removal. After washing, the minced tissue was suspended in enzyme-containing solution and cells isolated and placed in primary culture as described above for the rat duodenal mucosa.

Digitized video image analyses of duodenocytes in primary culture. Changes in [Ca2+]i were measured in fura 2-loaded cells, using the dual-wavelength excitation ratio technique (31) as previously described (20). Cells that had been cultured for 1-5 days on Matrigel-coated glass-bottomed 35-mm dishes (20) were loaded with fura 2 (8 µM fura 2-AM for 30 min at 37°C), rinsed several times, and placed in a perfusion chamber on the warmed (37°C) stage of a Zeiss Axiovert microscope. Fluorescence in single cells was monitored at 340 and 380 nm excitation and 510 nm emission and quantitated with a GenIIsys light-amplified charge-coupled device (CCD) 72 video camera (DAGE-MTI, Michigan City, IN) using Inovision IC300 software (Research Triangle Park, NC) supported by a SUN 4/330 computer (Palo Alto, CA). Changes in [Ca2+]i were expressed as the ratio of fluorescence intensities at 340 and 380 nM, as described previously (20). Images of cells and cell colonies were acquired with a DAGE 72 CCD camera and printed from the computer monitor with a UP 5000P printer (Sony).

Chemicals and drugs. CCK-8 (fragment 26-33) was from Peninsula Europe (Merseyside, UK). Atropine sulfate, EGTA, BSA (fraction V, pH 7, sterile 35% solution), sodium bicarbonate (sterile 7.5% solution, cell culture tested), carbachol (carbamylcholine chloride), collagenase type IA, DTT, DMEM-F12 (1:1 mixture with L-glutamine and 15 mM HEPES, without sodium bicarbonate), HEPES, gentamicin, and VIP (porcine) were obtained from Sigma Chemical (St. Louis, MO). Fura 2-AM was from Calbiochem (La Jolla, CA). Dispase II was purchased from Boehringer (Mannheim, Germany), Matrigel from Collaborative Biomedical Products (Bedford, MA), and FCS from Harlan Sera-Lab (Loungborough, UK). The muscarinic antagonists atropine, methoctramine tetrahydrochloride, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), and pirenzepine dihydrochloride were from Research Biochemicals (Wayland, MA). The M3-selective antagonist 11-({2-[(diethylamino)methyl]1-piperidinyl}acetyl)5,11-dihydro-6H-pyrido(2,3-beta )(1,4)benzodiazepin-6-one (AF-DX 116BS) was a generous gift from Karl Thomae (Biberach, Germany).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Primary culture of rat and human duodenocytes. Initial cell fractions isolated from duodenal collagenase digests were enriched in columnar cells with villus enterocyte morphology (Fig. 1A). These cells, when attached in small groups, exhibited spontaneous active movement between 1 and 3 days of culture (not shown). In contrast, cellular fractions obtained after successive triturations were composed predominately of cells with rounded, vacuolated morphologies (Fig. 1A) characteristic of crypt cells (30). These vacuolated cells retained such morphologies for 2-3 days. Within 3-4 days of plating, small colonies of epithelial cells with distinct morphologies began to form and by days 7-10 "domes" characteristic of actively secreting cell types were evident (Fig. 1B). Importantly, duodenocytes did not attach to the matrix if collagenase was not used during the preparation procedure. Cells also did not attach as well if the mucosa was dissected away from the underlying substratum by blistering compared with our standard scraping protocol.


View larger version (77K):
[in this window]
[in a new window]
 


View larger version (102K):
[in this window]
[in a new window]
 
Fig. 1.   Duodenal enterocytes (duodenocytes) can be maintained in primary culture for several weeks, and cells with villus-like morphologies are present for at least 24 h in these cultures. A: duodenocyte fractions with villus and crypt-like morphologies are readily identified between 8 and 24 h of culture. Left: 2 villus cells after 8 h in culture. Middle: after 24 h, some villus cells become rounded, but others retain a columnar appearance. Right: after 24 h in culture, cells from crypt fractions are often found to contain secretory vacuoles. B: duodenocytes begin to divide and form discrete colonies after several days in culture. Shown are images from 2 different 4-day cultures of rat duodenocytes. Such colonies remained viable for at least 3 wk of culture. Bar, 20 µm. Left: arrow indicates dome formation in center of colony. Right: no domes are evident in this colony.

Effects of carbachol on [Ca2+]i signaling in single duodenocytes. Carbachol consistently increased [Ca2+]i in rat duodenocytes in primary culture. Moreover, the carbachol-induced increase in [Ca2+]i in these cells was reproducibly observed even after several days of culture (Fig. 2). Two types of signaling patterns were observed in duodenocytes. In the first, [Ca2+]i spiked rapidly and returned to basal or near basal values within 3-5 min after carbachol addition (Fig. 2). In the second, which was predominately observed in cells with enlarged vacuoles as described for secreting crypt cells (30), the initial Ca2+ transient was followed by slow, rhythmic oscillations in [Ca2+]i of lower amplitude. The oscillatory patterns varied between cells and oscillations were usually not sustained. A typical pattern and frequency is shown in Fig. 3A in two cells from the same duodenal preparation. Selected images of these fura 2-loaded cells are shown in Fig. 3B.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Although most experiments were performed within 24-48 h after cells were placed in culture, carbachol continued to induce increases in intracellular calcium concentration ([Ca2+]i) in rat duodenocytes even after several days in primary culture. In contrast, cells with fibroblast-like morphologies did not respond to cholinergic stimulation. Shown are recordings of [Ca2+]i signals (10 µM carbachol present as indicated), as measured with fura 2, in 5 duodenocytes and 2 fibroblasts (not responding). Measurements were performed on the 5th day of culture.


View larger version (16K):
[in this window]
[in a new window]
 


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Example of rhythmic oscillations in [Ca2+]i induced by carbachol in a subpopulation of rat duodenocytes with large secretory vesicles. Top: recordings of [Ca2+]i signals before and after addition of 10 µM carbachol. Bottom: selected images of cells from which recordings were obtained. Bar, 5 µm. A: transmitted light image before carbachol addition. B: fura 2 fluorescence ratio before carbachol addition. C: increase in fura 2 fluorescence ratio during peak carbachol response (darkened edges of image were off scale). D: transmitted light image at the end of the experiment showing expansion of cellular vacuoles.

In contrast to the transient increase in [Ca2+]i observed in rat duodenocytes, human duodenocytes isolated from biopsies consistently responded to carbachol with an initial spike followed by a sustained plateau (Fig. 4). Furthermore, rhythmic oscillations in [Ca2+]i were not observed in duodenocytes from human biopsies. The increase in [Ca2+]i elicited by the cholinergic agonist carbachol was dose dependent with an EC50 of ~3 × 10-6 M in human (Fig. 4) as well as in rat (not shown) duodenocytes.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Similar to rat duodenocytes, human duodenocytes responded to increasing concentrations of carbachol in a dose-dependent fashion. For recordings depicted, duodenocytes were isolated from a biopsy from a 40-yr-old female and cultured for ~24 h before loading with fura 2. Data shown are from 5 duodenocytes and are representative of 30 cells (6 experiments with biopsies from 6 subjects aged 36-66 yr). Note the more sustained [Ca2+]i plateau in response to carbachol compared with the transient increase in rat duodenocytes (Figs. 2 and 3).

Effects of muscarinic receptor-selective antagonists. To define muscarinergic receptor subtypes present on duodenocytes, we tested several selective antagonists, including the M3-selective antagonist 4-DAMP, the M2-selective antagonists AF-DX 116BS and methoctramine, the M1-selective antagonist pirenzepine, and the nonselective antagonist atropine. In an initial series of experiments, nanomolar concentrations of 4-DAMP were found to dose dependently inhibit the increase in [Ca2+]i induced by 10 µM carbachol in human duodenocytes (Fig. 5). In other, less extensive experiments with rat duodenocytes, nanomolar concentrations of 4-DAMP were similarly effective in suppressing the increase in [Ca2+]i in response to 10 µM carbachol. Interestingly, higher concentrations of 4-DAMP reduced the "steady-state" increase in [Ca2+]i more potently than the initial, transient peak in [Ca2+]i (Fig. 5D).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Carbachol-induced increase in [Ca2+]i in human duodenocytes is potently suppressed by nanomolar concentrations of the muscarinic M3-selective receptor antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP). Shown are recordings from 5 duodenocytes that were obtained from a duodenal mucosal biopsy of a 57-yr-old female with normal duodenal mucosa. Cells were cultured for ~24 h before Ca2+ measurements were performed. Data are representative of results from 37 cells isolated from 3 female patients (36-57 yr of age).

To further characterize the actions of 4-DAMP on carbachol-induced Ca2+ fluxes, experiments were conducted with human duodenocytes in the presence and nominal absence of extracellular Ca2+. As expected based on the pattern of the Ca2+ signaling response to carbachol, chelation of Ca2+ medium with EGTA abolished the plateau phase but not the initial increase in [Ca2+]i induced by carbachol (Fig. 6C). Thus, as in other cell types, it appears that carbachol causes both release of Ca2+ from intracellular stores and influx of extracellular Ca2+ in human duodenocytes. Although there was some variability in the effects of 4-DAMP on the peak vs. the plateau phase of the [Ca2+]i response to carbachol (compare Figs. 5 and 6), the data presented in Fig. 6 show that EGTA addition in the presence of a submaximal inhibitory concentration of 4-DAMP almost completely abolished the carbachol-induced increase in [Ca2+]i (Fig. 6B). Moreover, when 4-DAMP was added in the presence of extracellular Ca2+, the carbachol-induced increase in [Ca2+]i was slightly delayed compared with the increase in [Ca2+]i induced by carbachol alone (Fig. 6, A and D). Because EGTA is expected to primarily prevent Ca2+ influx, these combined data support the conclusion that 4-DAMP potently suppresses the carbachol-induced release of intracellular Ca2+.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   Differential effects of extracellular Ca2+ chelation on carbachol-induced elevation of [Ca2+]i in the presence and absence of 4-DAMP. Compared with the response to carbachol alone, a submaximal concentration of 4-DAMP (3 nM) caused a slight delay in the initial carbachol-induced increase in [Ca2+]i and strongly suppressed the plateau phase of the response (compare A and D). Chelation of extracellular Ca2+ with EGTA suppressed the plateau phase of the carbachol response but not the initial transient increase in [Ca2+]i (compare C and D). In contrast, 4-DAMP almost completely abolished the response to carbachol when EGTA was present (compare B and C). Taken together, these results and those in Fig. 5 suggest that both phases of the carbachol-induced increase in [Ca2+]i are suppressed by 4-DAMP. The EGTA data further suggest that the release of Ca2+ from intracellular store(s) is potently affected by the inhibitor. Recordings are from 6 duodenocytes that were originally isolated from the same human mucosal biopsy as used in Fig 5. Cells were in primary culture for ~24 h before use.

In contrast to the potent inhibition by the M3-selective antagonist 4-DAMP, similar nanomolar (<= 1 µM) concentrations of the M1-selective antagonist pirenzepine (Fig. 7) as well as of the M2-selective antagonist AF-DX 116BS (Fig. 8) did not significantly inhibit the response to carbachol. At higher concentrations, the M1- and M2-selective antagonists did suppress the carbachol-induced increase in [Ca2+]i, presumably because of a nonspecific action on M3 receptors. With pirenzepine, a concentration of 1 µM reduced the steady-state increase in [Ca2+]i and the highest concentration tested (10 µM) reduced the transient as well the steady-state increase in [Ca2+]i. The latter effect was observed also with 10 µM (but not with 1 µM) AF-DX 116BS. Results with rat (not shown) and human duodenocytes were similar.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   In contrast to 4-DAMP, micromolar concentrations of the M1-selective antagonist pirenzepine (pir.) are required to suppress the carbachol-induced increase in [Ca2+]i. Duodenocytes from a 57-yr-old female patient were placed in primary culture for ~24 h before Ca2+ measurements. Data are representative of results from 22 cells in primary culture initially isolated from duodenal biopsies from 2 female patients (ages 36 and 57 yr).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 8.   Similar to the M1-receptor antagonist pirenzepine only very high (micromolar) concentrations of the M2-selective antagonist AF-DX 116BS (AF-DX) were capable of suppressing the carbachol-induced increase in [Ca2+]i in duodenocytes. Shown are recordings from 6 duodenocytes that were isolated from a duodenal biopsy of a 57-yr-old female and cultured for ~24 h. Data are representative of results with 24 cells in 4 different experiments (4 subjects, 36-57 yr).

The reproducibility of the responses and difference in effects of the muscarinic receptor-selective antagonist in the same human duodenocyte are depicted in Fig. 9. In addition, the actions of methoctramine, another M2-selective antagonist, and the subtype-independent muscarinic antagonist atropine were examined. As expected, atropine, but not methoctramine inhibited the increase in [Ca2+]i in response to carbachol (Fig. 9). This difference between atropine and methoctramine was also observed in rat duodenocytes (not shown).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 9.   Comparison of differential effects of the muscarinic receptor antagonists 4-DAMP, AF-DX 116BS, pirenzepine, methoctramine, and atropine. Shown is a continuous recording of [Ca2+]i in a single human duodenocyte. Data demonstrate the reproducibility of [Ca2+]i responses of human duodenocytes (compare with recordings in Figs. 5, 7, and 8) as well as the expected inhibition by atropine and lack of inhibition by methoctramine, another M2-selective antagonist.

Effects of CCK and VIP. CCK released postprandially from the duodenal mucosa is an interesting potential stimulus of intestinal secretion; however, CCK actions at the enterocyte level have not been characterized. The octapeptide of CCK, consisting of the carboxy-terminal eight amino acids (CCK-8), is the most biologically potent small peptide of CCK that has been isolated. Similar to carbachol, CCK-8 increased [Ca2+]i in rat (Fig. 10) as well as in human (Fig. 11) duodenocytes. Comparing the [Ca2+]i response of CCK-8 (10 nM) with that of 10 µM carbachol in rat duodenocytes (Fig. 10), it appears that the responses are of similar magnitude. Moreover, although the CCK response has not yet been studied in depth, the data suggest the [Ca2+]i response to CCK in human duodenocytes is rapidly downregulated as was previously observed with respect to the CCK/gastrin response in the gastric parietal cell (5). Thus, in Fig. 11, the response to 500 nM CCK-8 was smaller than that to the preceding exposure to 50 nM CCK-8. Furthermore, 1 nM CCK failed to elicit an increase in [Ca2+]i when administered after a higher dose of CCK had been removed. When 1 nM CCK was added initially, a response could be elicited (not shown).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 10.   CCK-8 induces an increase in [Ca2+]i in rat duodenocytes. Shown are representative recordings from 2 cells cultured for ~24 h. Cells were first stimulated with carbachol to show specific response patterns for the sampled cells. After removal of carbachol, cells were then stimulated with CCK-8. Although oscillations in [Ca2+]i were not observed in all cells, similar initial spike responses to CCK-8 were detected in 19 rat duodenocytes isolated from 6 different animals.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 11.   Human duodenocytes also respond not only to carbachol but also to the peptide hormone CCK-8 with an increase in [Ca2+]i. In contrast to carbachol, the response to CCK-8 is rapidly downregulated (compare with Fig. 4). Shown is a representative recording from a single duodenocyte from an ~24-h primary culture of duodenocytes isolated from a normal mucosal biopsy of a 66-yr-old female. Similar responses to CCK were obtained in 12 human duodenocytes from 3 separate biopsy experiments.

In vivo, VIP and prostaglandin E2 stimulate the secretion of HCO-3 in the duodenum of all mammalian species tested, including in rats and humans (8). However, in isolated duodenocytes from humans, VIP (10-9-10-6 M, 3 experiments, 20 cells) did not induce an increase in [Ca2+]i (not shown). Prostaglandin E2 (1 µM) tested in one experiment with human duodenocytes was similarly without efffect.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The results presented in this study demonstrate, for the first time, that viable, agonist-responsive enterocytes from both crypt and villus regions of human and rat duodenal mucosae can be isolated and maintained in primary culture for several days. In addition, dividing colonies of agonist-responsive cells with epithelial-like morphologies, originating from the initial cell isolates, could be sustained in culture for at least 3-4 wk. Because of the possibility of actions at several sites of muscarinic and other secretory agonists in the intact animal in vivo, the use of isolated duodenocytes seems a prerequisite for the demonstration of the presence of enterocyte-specific receptor subtypes as well as for defining the intracellular signaling pathways activated by these agonists. In developing the models used here, cells were isolated only from young adult rats and from adult human biopsies. Thus potential problems with undeveloped expression of receptors that might occur with use of cells from immature (fetal) animals or from transformed cells lines were avoided.

The current model was developed using modifications of a technique previously used to establish and characterize a primary culture model of gastric parietal cells (3, 20). An important factor in the initial cell isolation steps was the omission of EDTA and the use of a relatively gentle trituration technique, rather than vibration, to isolate villus and crypt-enriched fractions (see Ref. 6 for a review of previously used intestinal cell isolation techniques). The use of a mild enzymatic digestion protocol and the inclusion of DTT to break mucus disulfide bonds were further found to be important prerequisites for cell attachment. Previous studies with gastric parietal cells have shown Matrigel to be an ideal attachment matrix for this cell type (3, 20). In this study, although cell attachment factors were not systematically examined, a thin coating of dilute Matrigel was also found to be a reliable attachment matrix for both human and rat duodenocytes. It should be noted that in an earlier study, we found collagen I to be a superior attachment factor for acutely isolated, single duodenocytes that had been exposed to Ca2+ chelators (16). It remains to be determined whether or not these differences are the result of differences in cell isolation techniques or are related to the plating conditions with cell clumps vs. single cell isolates.

Our results with duodenocytes in primary culture show that cells with crypt and villus-like morphologies from both humans and rats respond to carbachol with a dose-dependent increase in [Ca2+]i. These data contrast with previous results obtained with human jejunal biopsies and in rat enterocytes isolated using a hyaluronidase digestion technique (13) in which there was no detectable response to cholinergic agonists in fura 2-loaded cells. The divergence in stimulatory pathways and transport characteristics between duodenal mucosa, capable of transporting HCO-3 at high rates (8), and jejunal mucosa may contribute to this difference. It would seem likely, however, that the improved responsiveness is due to the fact that duodenocytes are 1) isolated by a more gentle enzymatic technique, 2) not exposed to Ca2+ chelators, and 3) placed in primary culture to allow for recovery from the initial insults of tissue dissociation. Interestingly, we (unpublished observation) and others (13, 28) have found that the cAMP signaling pathway is much less sensitive to initial Ca2+ chelation and harsher enzymatic digestion protocols.

On the basis of our pharmacological analyses in which a pattern of inhibition characteristic of the M3 receptor subtype was observed (i.e., 4-DAMP >>  pirenzepine > AF-DX 116BS) (2), we conclude that M3 muscarinic receptor subtypes are present on both crypt and villus-like cells and are linked to the Ca2+ signaling pathway in these cells. To date, five different muscarinic receptor subtypes have been cloned (2). M1 and M3 receptors have been shown to be linked to phosphoinositol turnover and the Ca2+ signaling pathway and are generally stimulatory. M2 (and M4 receptors) are linked to adenylyl cyclase and are generally involved in mediating inhibitory effects. Within the intestine, muscarinic agonists have several well-documented sites of action, including the ion-transporting enterocytes, postsynaptic axons, and presynaptic terminals in the enteric nervous system. Previous studies of the neurohumoral control of duodenal mucosal HCO-3 secretion (9, 21, 27, 29) have suggested that cholinergic stimulation of the duodenal secretion involves muscarinic M1 and M2 receptors as well as nicotinic receptors. The central nervous system and the peripheral sympathetic ganglia provide additional possible sites of action in the intact animal, and one site of action may dominate in a particular experimental protocol. For example, the muscarinic M1-receptor antagonists pirenzepine and telenzepine did not inhibit but caused a dose-dependent increase in duodenal mucosal secretion HCO-3 secretion in a study in anesthetized rats (27). Pretreatment with the adrenoceptor antagonist phentolamine prevented the increase in secretion, suggesting that pirenzepine and telenzepine acted in a stimulatory manner by antagonizing M1 transmission in sympathetic ganglia thereby decreasing postsynaptic alpha -adrenoceptor-mediated inhibition of the secretion.

The possibility of direct regulation of duodenocytes by muscarinic M3 receptors, as demonstrated in the present study, has not been considered previously. However, cholinergic actions mediated by this receptor subtype have been demonstrated in several tissues (2), including stimulation of H+ secretion by gastric parietal cells (24, 32) and 125I efflux in the T84 colonic cell line (7). In addition, pharmacological characterization of the carbachol response in isolated rat distal colonic mucosa has suggested the involvement of muscarinic M3 receptors (23).

In the present study, the pattern of carbachol-induced increase in [Ca2+]i in rat duodenocytes was typically transient, returning to basal or near basal values within 3-5 min after the initial peak response. In contrast, in human duodenocytes the initial transient peak was very reproducibly followed by a sustained plateau in [Ca2+]i. This biphasic Ca2+ response to carbachol is characteristic of many other nonexcitable cell types and a substantial amount of evidence indicates that the initial spike in [Ca2+]i is the result of release of Ca2+ from an intracellular storage site(s), whereas the later sustained phase is due to the influx of Ca2+ across the cell membrane. This also appears to be the case for duodenocytes, because as shown here chelation of extracellular Ca2+ leads to the abolishment of the plateau phase but not the initial increase in [Ca2+]i elicited by carbachol. Thus our results with submaximal inhibitory concentrations of 4-DAMP and the extracellular Ca2+ chelator EGTA suggest that this M3-receptor antagonist is a more potent inhibitor of carbachol-stimulated release of intracellular Ca2+ than of Ca2+ entry. These data are in line with a previous report by Wilkes et al. (32) who found that 4-DAMP is a more potent inhibitor of intracellular Ca2+ release (EC50 ~1.7 nM) than influx (EC50 >30 nM) in the gastric parietal cell.

Although not observed in human duodenocytes, we found that a subpopulation of rat duodenocytes with enlarged vacuoles, as described for crypt-like secreting enterocytes (30), responded to carbachol and CCK-8 with an initial transient increase in [Ca2+]i followed by rhythmic oscillations in [Ca2+]i of lower amplitude (~<FR><NU>1</NU><DE>5</DE></FR> min). The reason for these differences between rat and human Ca2+ signaling patterns is presently unclear but may be related to either differences in maturity or to secretory status of the cells that were studied. Agonists that provoke inositol lipid hydrolysis have been shown to induce oscillations in [Ca2+]i in some, but not all, nonexcitable cell types, but the physiological significance of these oscillations is not clearly established. For example, carbachol induces sustained oscillations in [Ca2+]i in mouse pancreatic beta -cells exposed to 20 mM (but not in such cells exposed to 3 mM) of glucose (12). In rabbit cultured gastric parietal cells (20), carbachol induced apparently rhythmic oscillations but only at concentrations below the half-maximal concentration for initiation of acid secretion. Moreover, higher concentrations of carbachol (>1 µM), which did initiate a secretory response, induced only a transient spike followed by a sustained elevation of [Ca2+]i in these cells.

In contrast to the cholinergic signaling pathway, other agonists that stimulate duodenal mucosal HCO-3 secretion have been shown to increase cAMP production. For example, dopamine D1-receptor agonists, which stimulate HCO-3 secretion in rat (9) and human (18) duodenum in vivo, increased cAMP production in fractions of crypt as well as in fractions of villous duodenocytes from the rat (26). In addition, VIP, which is a potent secretory stimulant in all mammalian species tested (8), also increased cAMP production in crypt and villus duodenocytes from the rat (26) and guinea pig (25). Not unexpectedly, this peptide was not found to increase [Ca2+]i in the present study. It would thus seem highly likely that both the cAMP and the [Ca2+]i signaling pathways are important modulators of duodenocyte function(s). It has also recently been shown (11) that 8-bromo-cGMP as well as cGMP stimulate HCO-3 in rat duodenum in vitro.

With respect to the specific intracellular events activated by the cAMP and Ca2+ signaling pathways, studies of amphibian mucosa in vitro, of membrane vesicles, and of acutely isolated rat and rabbit duodenocytes (1, 8, 16) have indicated that duodenocytes import HCO-3 at the serosal membrane by NaHCO3 cotransport and export Cl-/HCO-3 exchange via an apical anion conductive pathway, recently suggested to be the cystic fibrosis transmembrane conductance regulator channel (11, 14). The cellular location (villus or crypt) within the duodenal mucosa of the secretory processes and their relation to the mode of intracellular signaling have, however, not yet been clarified. Electrogenic secretion of HCO-3 mediated by cAMP may, as suggested for secretion of Cl- by more distal small intestine, be a property of crypt cells. In contrast, villus cells may export HCO-3 by Cl-/HCO-3 exchange (8). However, the results of the present study suggest that villus as well as crypt cells respond to muscarinic M3 receptor stimulation with an increase in [Ca2+]i.

CCK released postprandially from the duodenal mucosa is an interesting potential stimulus of duodenal mucosal HCO-3 secretion, but contraction of the smooth muscular layers induced by CCK and obstructing luminal perfusion makes it experimentally difficult to interpret actions of this hormone on intestinal electrolyte transport in intact animals. The presence of CCK receptors at vagal afferent fibers may pose a further problem in elucidating results. Studies of distal ileum, stripped of the longitudinal muscle layer and mounted in an in vitro chamber (17), have suggested that CCK acts at enteric neuronal receptors to stimulate mucosal short-circuit current (anion secretion), in part by release of ACh. Actions of CCK at the enterocyte level have not been reported before. The results of the present study indicate that, similar to carbachol, CCK-8 increases [Ca2+]i in isolated duodenocytes. Thus it would seem most likely that CCK exerts a direct stimulatory effect on the duodenocyte in vivo. Interestingly, the duodenocyte [Ca2+]i response seems rapidly downregulated as was previously observed with respect to the response to CCK and gastrin in the gastric parietal cell (5).

In summary, the results of the present study indicate that muscarinic receptors are present on both human and rat duodenocytes and are M3 in nature. Because these duodenocytes respond not only to the cholinergic agonist carbachol but also to the peptide hormone CCK-8 with an increase in [Ca2+]i, our results further suggest that postprandially released CCK, similar to cholinergic stimuli, may be involved in stimulating duodenocyte HCO-3 secretion and protecting the duodenum against acid discharged from the stomach.

    ACKNOWLEDGEMENTS

We thank Drs. Lars Knutson and Mikael Ljungdal, (Dept. of Surgery, Uppsala University Hospital) for providing biopsies of human duodenum, Dr. Magnus Ljungström for help with the imaging system, and Gunilla Jedstedt for skillful technical assistance.

    FOOTNOTES

This study was supported by Swedish Medical Research Council Grants 04V-10651 and 04X-3515, Swedish National Board for Laboratory Animals Grant 94-14, and by the Thuring Foundation (Stockholm, Sweden). C. S. Chew was the recipient of a Swedish Medical Research Council Visiting Professorship.

Address for reprint requests: G. Flemström, Dept. of Physiology, Uppsala Univ. Biomedical Center, PO Box 572, SE-751 23 Uppsala, Sweden.

Received 31 December 1997; accepted in final form 15 April 1998.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Ainsworth, M. A., M. Amelsberg, D. L. Hogan, and J. I. Isenberg. Acid-base transport in isolated rabbit duodenal villus and crypt cells. Scand. J. Gastroenterol. 31: 1069-1077, 1996[Medline].

2.   Caulfield, M. P. Muscarinic receptors: characterization, coupling and function. Pharmacol. Ther. 58: 319-379, 1993[Medline].

3.   Chew, C. S. Parietal cell culture: new models and directions. Annu. Rev. Physiol. 56: 445-461, 1994[Medline].

4.   Chew, C. S., M. Ljungström, A. Smolka, and M. R. Brown. Primary culture of secretagogue-responsive parietal cells. Am. J. Physiol. 256 (Gastrointest. Liver Physiol. 19): G254-G263, 1989[Abstract/Free Full Text].

5.   Chew, C. S., K. Nakamura, and M. Ljungström. Calcium signaling patterns in the gastric parietal cell. Yale J. Biol. Med. 65: 561-576, 1992[Medline].

6.   Dawson, J. R., and M. Schwenk. Isolated epithelial cells. Progr. Pharmacol. Clin. Pharmacol. 7: 21-41, 1989.

7.   Dickinson, K. E. J., R. A. Frizzell, and M. C. Sekar. Activation of T84 cell chloride channels by carbachol involves a phosphoinositide-coupled muscarinic M3 receptor. Eur. J. Pharmacol. 225: 291-298, 1992[Medline].

8.   Flemström, G. Gastric and duodenal mucosal bicarbonate secretion. In: Physiology of the Gastrointestinal Tract (3rd ed.), edited by L. R. Johnson. New York: Raven, 1994, p. 1285-1309.

9.   Flemström, G., B. Säfsten, and G. Jedstedt. Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology 104: 825-833, 1993[Medline].

10.   Glad, H., P. Svendsen, O. Olesen, and O. B. Schaffalitzky de Muckadell. Importance of vagus nerves in duodenal acid neutralization in anesthetized pigs. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G154-G160, 1997[Abstract/Free Full Text].

11.   Guba, M., M. Kuhn, W. G. Forssmann, M. Classen, M. Gregor, and U. Seidler. Guanylin strongly stimulates rat duodenal HCO-3 secretion: proposed mechanism and comparison with other secretagogues. Gastroenterology 111: 1558-1568, 1996[Medline].

12.   Gylfe, E. Carbachol induces sustained glucose-dependent oscillations of cytoplasmic Ca2+ in hyperpolarized pancreatic beta  cells. Pflügers Arch. 419: 639-643, 1991[Medline].

13.   Hitchin, B. W., P. R. Dobson, B. L. Brown, J. Hardcastle, P. T. Hardcastle, and C. J. Taylor. Measurement of intracellular mediators in enterocytes isolated from jejunal biopsy specimens of control and cystic fibrosis patients. Gut 32: 839-899, 1991.

14.   Hogan, D. L., D. L. Crombie, J. I. Isenberg, P. Svendsen, O. B. Schaffalitzky de Muckadell, and M. A. Ainsworth. CFTR regulates cAMP- and Ca2+-mediated duodenal epithelial HCO3 secretion. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G872-G876, 1997[Abstract/Free Full Text].

15.   Hogan, D. L., B. Yao, J. H. Steinbach, and J. I. Isenberg. The enteric nervous system modulates mammalian duodenal mucosal bicarbonate secretion. Gastroenterology 105: 410-417, 1993[Medline].

16.   Isenberg, J. I., M. Ljungström, B. Säfsten, and G. Flemström. Proximal duodenal enterocyte transport: evidence for Na+-H+ and Cl--HCO-3 exchange and NaHCO3 cotransport. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G677-G685, 1993[Abstract/Free Full Text].

17.   Kachur, J. R., G. L. Phillips, and T. S. Gaginella. Neuromodulation of guinea pig intestinal electrolyte transport by cholecystokinin octapeptide. Gastroenterology 100: 344-349, 1991[Medline].

18.   Knutson, L., T. W. Knutson, and G. Flemström. Endogenous dopamine and duodenal bicarbonate secretion in humans. Gastroenterology 104: 1409-1413, 1993[Medline].

19.   Lenz, H. J., W. W. Vale, and J. E. Rivier. TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G677-G682, 1989[Abstract/Free Full Text].

20.   Ljungström, M., and C. S. Chew. Calcium oscillations in single cultured gastric partietal cells. Am. J. Physiol. 260 (Cell Physiol. 29): C67-C78, 1991[Abstract/Free Full Text].

21.   Mertz-Nielsen, A., J. Hillingsø, O. Eskerod, K. Bukhave, and J. Rask-Madsen. Muscarinic M1 receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes prostaglandin E2 synthesis in healthy volunteers. Gut 36: 528-533, 1995[Abstract].

22.   Odes, H. S., R. Muallem, R. Reimer, W. Beil, M. Schwenk, and K.-F. Sewing. Cholinergic regulation of guinea pig duodenal bicarbonate secretion. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G270-G276, 1993[Abstract/Free Full Text].

23.   O'Malley, K. E., C. B. Farrel, K. M. O'Boyle, and A. W. Baird. Cholinergic characterization of Cl- secretion in rat colonic epithelia. Eur. J. Pharmacol. 275: 83-89, 1995[Medline].

24.   Pfeiffer, A., H. Rochlitz, B. Noelke, R. Tacke, U. Moser, E. Mutschler, and G. Lambrecht. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology 98: 218-222, 1990[Medline].

25.   Reimer, R., H. S. Odes, R. Muallem, M. Schwenk, W. Beil, and K. F. Sewing. Cyclic adenosine monophosphate is the second messenger of prostaglandin E2- and vasoactive intestinal polypeptide-stimulated active bicarbonate secretion by guinea pig duodenum. Scand. J. Gastroenterol. 29: 153-159, 1994[Medline].

26.   Säfsten, B., and G. Flemström. Dopamine and vasoactive intestinal peptide stimulate cyclic adenosine 3',5'monophosphate formation in isolated rat villus and crypt duodenocytes. Acta Physiol. Scand. 149: 67-75, 1993[Medline].

27.   Säfsten, B., G. Jedstedt, and G. Flemström. Cholinergic influence on duodenal mucosal bicarbonate secretion in the anesthetized rat. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G10-G17, 1994[Abstract/Free Full Text].

28.   Smith, J. A., M. Griffin, S. E. Mireylees, and R. G. Long. Effect of vasoactive intestinal peptide on cyclic adenosine monophosphate production in enterocytes isolated from human duodenal biopsy specimens. Gut 31: 1350-1354, 1990[Abstract].

29.   Takeuchi, K., H. Niida, and S. Okabe. Characterization of alkaline response induced by cholinergic agents in the rat duodenum: involvement of M2 receptors and the calcium-dependent process. J. Pharmacol. Exp. Ther. 254: 465-470, 1990[Abstract].

30.   Trier, J. S. Studies of the small intestinal crypt epithelium. II. Evidence for and mechanisms of secretory activity by undifferentiated crypt cells of the human small intestine. Gastroenterology 47: 480-495, 1964.

31.   Tsien, R. Y., T. J. Rink, and M. Poenie. Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium 6: 145-157, 1985[Medline].

32.   Wilkes, J. M., M. Kajimura, D. R. Scott, S. J. Hersey, and G. Sachs. Muscarinic responses of gastric parietal cells. J. Membr. Biol. 122: 97-110, 1991[Medline].


Am J Physiol Gastroint Liver Physiol 275(2):G296-G304
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society